News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
854,170 Results
Type
Article (86986)
Company Profile (704)
Press Release (766479)
Multimedia
Podcasts (152)
Webinars (19)
Section
Business (232872)
Career Advice (4133)
Deals (39768)
Drug Delivery (130)
Drug Development (91134)
Employer Resources (199)
FDA (18208)
Job Trends (17372)
News (396955)
Policy (39840)
Tag
Academia (3002)
Academic (2)
Accelerated approval (14)
Adcomms (33)
Allergies (109)
Alliances (56977)
ALS (123)
Alzheimer's disease (1614)
Antibody-drug conjugate (ADC) (192)
Approvals (18163)
Artificial intelligence (409)
Autoimmune disease (39)
Automation (20)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (103)
Brain cancer (41)
Breast cancer (408)
Cancer (3205)
Cardiovascular disease (258)
Career advice (3542)
Career pathing (34)
CAR-T (214)
CDC (43)
Cell therapy (590)
Cervical cancer (25)
Clinical research (74485)
Collaboration (1155)
Company closure (3)
Compensation (733)
Complete response letters (38)
COVID-19 (2915)
CRISPR (70)
C-suite (389)
Cystic fibrosis (124)
Data (3258)
Decentralized trials (2)
Denatured (54)
Depression (83)
Diabetes (384)
Diagnostics (6995)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (193)
Drug pricing (156)
Drug shortages (36)
Duchenne muscular dystrophy (160)
Earnings (97829)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131628)
Executive appointments (925)
FDA (20084)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1039)
Gene editing (152)
Generative AI (42)
Gene therapy (463)
GLP-1 (946)
Government (5286)
Grass and pollen (7)
Guidances (221)
Healthcare (20920)
HIV (46)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (194)
Immuno-oncology (13)
Indications (42)
Infectious disease (3120)
Inflammatory bowel disease (167)
Inflation Reduction Act (13)
Influenza (78)
Intellectual property (130)
Interviews (813)
IPO (17907)
IRA (57)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (60)
Layoffs (602)
Leadership (27)
Legal (10139)
Liver cancer (85)
Longevity (12)
Lung cancer (449)
Lymphoma (224)
Machine learning (13)
Management (65)
Manufacturing (478)
MASH (104)
Medical device (14750)
Medtech (14756)
Mergers & acquisitions (22610)
Metabolic disorders (978)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (165)
Neuropsychiatric disorders (47)
Neuroscience (2409)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (51)
Obesity (497)
Opinion (292)
Ovarian cancer (107)
Pain (128)
Pancreatic cancer (133)
Parkinson's disease (204)
Partnered (25)
Patents (340)
Patient recruitment (187)
Peanut (55)
People (65796)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22977)
Phase II (32342)
Phase III (24361)
Pipeline (1787)
Policy (252)
Postmarket research (3554)
Preclinical (10380)
Press Release (72)
Prostate cancer (156)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (544)
Real estate (7402)
Recruiting (76)
Regulatory (27322)
Reports (62)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (12)
RSV (61)
Schizophrenia (104)
Series A (174)
Series B (120)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4307)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (71)
The Weekly (96)
Vaccines (940)
Venture capital (60)
Weight loss (334)
Women's health (52)
Worklife (20)
Date
Today (106)
Last 7 days (573)
Last 30 days (1991)
Last 365 days (33843)
2025 (19709)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1277)
Alabama (72)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50597)
Australia (8892)
California (8022)
Canada (2487)
China (742)
Colorado (342)
Connecticut (357)
Delaware (215)
Europe (116132)
Florida (1198)
Georgia (274)
Hawaii (3)
Idaho (67)
Illinois (759)
India (34)
Indiana (396)
Iowa (19)
Japan (248)
Kansas (117)
Kentucky (34)
Louisiana (19)
Maine (73)
Maryland (1133)
Massachusetts (6142)
Michigan (280)
Minnesota (501)
Mississippi (4)
Missouri (107)
Montana (32)
Nebraska (26)
Nevada (87)
New Hampshire (74)
New Jersey (2252)
New Mexico (31)
New York (2236)
North Carolina (1267)
North Dakota (10)
Northern California (3483)
Ohio (259)
Oklahoma (17)
Oregon (48)
Pennsylvania (1718)
Puerto Rico (18)
Rhode Island (40)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2985)
Tennessee (132)
Texas (1242)
United States (30261)
Utah (233)
Virginia (221)
Washington D.C. (80)
Washington State (705)
West Virginia (4)
Wisconsin (87)
There are 854,170 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Moderna Cutting 10% of Workforce Globally
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
August 1, 2025
·
172 min read
·
BioSpace Editorial Staff
Patents
Moderna Wins UK Patent Battle Against Pfizer and BioNTech
A U.K. Court of Appeals ruling confirms the validity of a patent covering modifications of mRNA used in Moderna’s vaccines.
August 1, 2025
·
2 min read
·
Dan Samorodnitsky
Earnings
Moderna’s Bancel Nay on M&A, Yay on R&D Partnerships
It’s not often that a CEO outright dismisses M&A prospects, but Moderna CEO Stéphane Bancel says the mRNA biotech has enough programs on its hands.
August 1, 2025
·
4 min read
·
Annalee Armstrong
FDA
After Prasad’s Ouster, Makary Looks for Better Drug, Biologic Alignment at FDA
The FDA has denied that it plans to combine the Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research into one entity.
August 1, 2025
·
2 min read
·
Tristan Manalac
Earnings
‘Very Impressive’ Amvuttra ATTR-CM Sales Send Alnylam Soaring
In its first commercial quarter for ATTR-cardiomyopathy, Alnylam’s Amvuttra reached roughly 1,400 patients and made more than $490 million.
August 1, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 1, 2025
·
16 min read
Layoffs
Merck’s $3B Savings Push Claims 6,000 Jobs
Merck has characterized its cost-cutting initiative as more of a reallocation of resources to support other, higher-growth areas of its business.
August 1, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights
August 1, 2025
·
9 min read
Press Releases
Regeneron Reports Second Quarter 2025 Financial and Operating Results
August 1, 2025
·
30 min read
Press Releases
ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET
August 1, 2025
·
1 min read
1 of 85,417
Next
